Kushkevych et al., 2022 - Google Patents
Effect of intestinal microbiome, antibiotics, and probiotics in the prevention and management of ulcerative colitisKushkevych et al., 2022
- Document ID
- 1958787982543630473
- Author
- Kushkevych I
- Jampílek J
- Publication year
- Publication venue
- Probiotics in the Prevention and Management of Human Diseases
External Links
Snippet
More and more people suffer from a variety of chronic inflammatory diseases, which are mainly caused by stress and a deteriorating environment. Chronic inflammatory bowel diseases are one of the most common such diseases. Their treatment is problematic and …
- 206010009900 Colitis ulcerative 0 title abstract description 182
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| You et al. | The promotion mechanism of prebiotics for probiotics: A review | |
| De Vrese et al. | Probiotics and prebiotics: effects on diarrhea | |
| Pandey et al. | Probiotics, prebiotics and synbiotics-a review | |
| Montalto et al. | Intestinal microbiota and its functions | |
| Bengmark | Bioecologic control of the gastrointestinal tract: the role of flora and supplemented probiotics and synbiotics | |
| Drissi et al. | Metabolic role of lactobacilli in weight modification in humans and animals | |
| ES2824536T3 (en) | Use of microbial communities for human and animal health | |
| RU2536939C2 (en) | Compositions containing probiotic and prebiotic ingredients and inorganic salts with lactoferrin | |
| WO2009154463A2 (en) | Butyrate as a medicament to improve visceral perception in humans | |
| He et al. | Effect of selenylation modification on antitumor activity of peptidoglycan from Lactobacillus acidophilus | |
| Huang et al. | Probiotics for the treatment of ulcerative colitis: a review of experimental research from 2018 to 2022 | |
| Gao et al. | Impact of prebiotics on enteric diseases and oxidative stress | |
| Faujdar et al. | Role of probiotics in human health and disease: an update | |
| Campaniello et al. | A narrative review on the use of probiotics in several diseases. Evidence and perspectives | |
| FR2906109A1 (en) | Food supplements, useful to prevent or combat urinary tract infections, comprise first preparation made of cranberry extract comprising proanthocyanidins and second preparation made of probiotics | |
| Elshaghabee et al. | Probiotics as a dietary intervention for reducing the risk of nonalcoholic fatty liver disease | |
| CN115484968A (en) | Stimulation of growth of bifidobacteria in the intestinal tract | |
| EP3866615B1 (en) | Dietary supplement for treating dysbiosis | |
| Yang et al. | Strategies for applying probiotics in the antibiotic management of Clostridioides difficile infection | |
| Kushkevych et al. | Effect of intestinal microbiome, antibiotics, and probiotics in the prevention and management of ulcerative colitis | |
| Park et al. | In vivo functional effects of Weissella confusa VP30 exopolysaccharides on loperamide-induced constipation in rats | |
| Arora et al. | Therapeutic potential of probiotics: A ray of hope or nightmare? | |
| Johnson | New food components and gastrointestinal health | |
| Bastani et al. | Health benefits of probiotic consumption | |
| Prasad et al. | MANAGEMENT OF HYPERURICEMIA AND GOUT BY PREBIOTICS AND PROBIOTICS: POTENTIALS AND LIMITATIONS. |